Published in Nature on May 13, 1993
3D domain swapping: a mechanism for oligomer assembly. Protein Sci (1995) 4.96
3D domain swapping: as domains continue to swap. Protein Sci (2002) 4.35
Domain swapping: entangling alliances between proteins. Proc Natl Acad Sci U S A (1994) 4.20
Structural biology of shared cytokine receptors. Annu Rev Immunol (2009) 2.27
A critical cytoplasmic domain of the interleukin-5 (IL-5) receptor alpha chain and its function in IL-5-mediated growth signal transduction. Mol Cell Biol (1994) 1.77
Interleukin-6: structure-function relationships. Protein Sci (1997) 1.59
Receptor recognition by gp130 cytokines. EMBO J (2000) 1.46
Th2 cytokines and asthma. The role of interleukin-5 in allergic eosinophilic disease. Respir Res (2001) 1.38
One sequence, two folds: a metastable structure of CD2. Proc Natl Acad Sci U S A (1995) 1.17
Structure of the active core of human stem cell factor and analysis of binding to its receptor kit. EMBO J (2000) 1.16
Crystal structure of dimeric human ciliary neurotrophic factor determined by MAD phasing. EMBO J (1995) 1.07
Interleukin-5 and IL-5 receptor in health and diseases. Proc Jpn Acad Ser B Phys Biol Sci (2011) 1.00
Specific human granulocyte-macrophage colony-stimulating factor antagonists. Proc Natl Acad Sci U S A (1994) 1.00
Hematopoietic cytokines: similarities and differences in the structures, with implications for receptor binding. Protein Sci (1993) 0.98
The acute phase reactant response to respiratory infection with Chlamydia pneumoniae: implications for the pathogenesis of atherosclerosis. Microbes Infect (2010) 0.95
Identification of receptor-binding domains on human interleukin 5 and design of an interleukin 5-derived receptor antagonist. Proc Natl Acad Sci U S A (1995) 0.95
An interleukin 5 mutant distinguishes between two functional responses in human eosinophils. J Exp Med (1997) 0.88
The cross-reactive calcium-binding pollen allergen, Phl p 7, reveals a novel dimer assembly. EMBO J (2002) 0.87
Mutagenesis in the C-terminal region of human interleukin 5 reveals a central patch for receptor alpha chain recognition. Proc Natl Acad Sci U S A (1995) 0.87
Cytokines in common variable immunodeficiency as signs of immune dysregulation and potential therapeutic targets - a review of the current knowledge. J Clin Immunol (2014) 0.86
Asymmetric usage of antagonist charged residues drives interleukin-5 receptor recruitment but is insufficient for receptor activation. Biochemistry (2006) 0.86
A cytokine-cytokine interaction in the assembly of higher-order structure and activation of the interleukine-3:receptor complex. PLoS One (2009) 0.84
Thiols decrease cytokine levels and down-regulate the expression of CD30 on human allergen-specific T helper (Th) 0 and Th2 cells. Clin Exp Immunol (2001) 0.84
Structural basis of interleukin-5 dimer recognition by its α receptor. Protein Sci (2012) 0.83
Detailed analysis of the IL-5-IL-5R alpha interaction: characterization of crucial residues on the ligand and the receptor. EMBO J (1995) 0.83
Mepolizumab in eosinophilic disorders. Expert Rev Clin Immunol (2011) 0.83
Docking studies on isoform-specific inhibition of phosphoinositide-3-kinases. J Chem Inf Model (2010) 0.81
Homology model of human interferon-alpha 8 and its receptor complex. Protein Sci (1995) 0.81
Monomeric isomers of human interleukin 5 show that 1:1 receptor recruitment is sufficient for function. Proc Natl Acad Sci U S A (1997) 0.80
Benzylpenicillin differentially conjugates to IFN-gamma, TNF-alpha, IL-1beta, IL-4 and IL-13 but selectively reduces IFN-gamma activity. Clin Exp Immunol (2003) 0.80
The Landscape of Intertwined Associations in Homooligomeric Proteins. Biophys J (2015) 0.78
Effects of reactive oxygen and nitrogen metabolites on RANTES- and IL-5-induced eosinophil chemotactic activity in vitro. Am J Pathol (1999) 0.78
A two-in-one antibody engineered from a humanized interleukin 4 antibody through mutation in heavy chain complementarity-determining regions. MAbs (2014) 0.77
Identification of interleukin genes in Pogona vitticeps using a de novo transcriptome assembly from RNA-seq data. Immunogenetics (2016) 0.76
Resonance assignments, secondary structure and topology of leukaemia inhibitory factor in solution. J Biomol NMR (1997) 0.76
Interleukin-5, a therapeutic target in allergic inflammation. Trans Am Clin Climatol Assoc (2000) 0.75
Molecular modeling of the GM-CSF and IL-3 receptor complexes. Protein Sci (1995) 0.75
Overview of the purification of recombinant proteins. Curr Protoc Protein Sci (2015) 0.75
Sequence-specific NMR resonance assignments for human interleukin-5. J Biomol NMR (2002) 0.75
Identification of a novel cytokine-like transcript differentially expressed in avian gammadelta T cells. Immunogenetics (2004) 0.75
The enigma of the near-symmetry of proteins: Domain swapping. PLoS One (2017) 0.75
Ligand binding and co-activator assembly of the peroxisome proliferator-activated receptor-gamma. Nature (1998) 8.33
CD4-independent infection by HIV-2 is mediated by fusin/CXCR4. Cell (1996) 6.52
Cloning of a disintegrin metalloproteinase that processes precursor tumour-necrosis factor-alpha. Nature (1997) 6.06
Crystal structure of the ribonuclease H domain of HIV-1 reverse transcriptase. Science (1991) 5.42
Molecular recognition of fatty acids by peroxisome proliferator-activated receptors. Mol Cell (1999) 4.32
A selective peroxisome proliferator-activated receptor delta agonist promotes reverse cholesterol transport. Proc Natl Acad Sci U S A (2001) 4.22
RANTES deposition by platelets triggers monocyte arrest on inflamed and atherosclerotic endothelium. Circulation (2001) 3.86
Potent inhibition of HIV-1 infectivity in macrophages and lymphocytes by a novel CCR5 antagonist. Science (1997) 3.84
CC chemokine receptor (CCR)4 and the CCR10 ligand cutaneous T cell-attracting chemokine (CTACK) in lymphocyte trafficking to inflamed skin. J Exp Med (2001) 3.51
The human nuclear xenobiotic receptor PXR: structural determinants of directed promiscuity. Science (2001) 3.27
Peroxisome proliferator-activated receptor gamma and metabolic disease. Annu Rev Biochem (2001) 3.17
Expression and characterization of the chemokine receptors CCR2 and CCR5 in mice. J Immunol (2001) 3.13
Glycosaminoglycans interact selectively with chemokines and modulate receptor binding and cellular responses. Biochemistry (1999) 3.07
Asymmetry in the PPARgamma/RXRalpha crystal structure reveals the molecular basis of heterodimerization among nuclear receptors. Mol Cell (2000) 3.01
The coordinated action of CC chemokines in the lung orchestrates allergic inflammation and airway hyperresponsiveness. J Exp Med (1998) 2.94
Molecular determinants of nuclear receptor-corepressor interaction. Genes Dev (1999) 2.92
Glycosaminoglycans mediate cell surface oligomerization of chemokines. Biochemistry (1997) 2.87
Aminooxypentane-RANTES induces CCR5 internalization but inhibits recycling: a novel inhibitory mechanism of HIV infectivity. J Exp Med (1998) 2.76
The pregnane X receptor: a promiscuous xenobiotic receptor that has diverged during evolution. Mol Endocrinol (2000) 2.74
Anatomy of a proficient enzyme: the structure of orotidine 5'-monophosphate decarboxylase in the presence and absence of a potential transition state analog. Proc Natl Acad Sci U S A (2000) 2.61
CD21 is a ligand for CD23 and regulates IgE production. Nature (1992) 2.58
A broad-spectrum chemokine antagonist encoded by Kaposi's sarcoma-associated herpesvirus. Science (1997) 2.58
Regulation of protein function by glycosaminoglycans--as exemplified by chemokines. Annu Rev Biochem (2005) 2.57
Extension of recombinant human RANTES by the retention of the initiating methionine produces a potent antagonist. J Biol Chem (1996) 2.56
Peroxisome proliferator-activated receptors: from genes to physiology. Recent Prog Horm Res (2001) 2.46
Molecular cloning and functional expression of a novel CC chemokine receptor cDNA from a human basophilic cell line. J Biol Chem (1995) 2.38
Phorbol esters and SDF-1 induce rapid endocytosis and down modulation of the chemokine receptor CXCR4. J Cell Biol (1997) 2.35
Dendritic cells are recruited into the airway epithelium during the inflammatory response to a broad spectrum of stimuli. J Exp Med (1996) 2.19
A key role for CC chemokine receptor 4 in lipopolysaccharide-induced endotoxic shock. J Exp Med (2000) 2.17
Receptor expression and responsiveness of human dendritic cells to a defined set of CC and CXC chemokines. J Immunol (1997) 2.02
Augmented expression of cyclooxygenase-2 in human atherosclerotic lesions. Am J Pathol (1999) 2.00
Atomic structure of PDE4: insights into phosphodiesterase mechanism and specificity. Science (2000) 1.98
Bacterial lipopolysaccharide rapidly inhibits expression of C-C chemokine receptors in human monocytes. J Exp Med (1997) 1.97
Structural determinants of ligand binding selectivity between the peroxisome proliferator-activated receptors. Proc Natl Acad Sci U S A (2001) 1.93
CXCR4 as a functional coreceptor for human immunodeficiency virus type 1 infection of primary macrophages. J Virol (1998) 1.81
The BBXB motif of RANTES is the principal site for heparin binding and controls receptor selectivity. J Biol Chem (2000) 1.73
Identification of a glycosaminoglycan binding surface on human interleukin-8. Biochemistry (1998) 1.71
Mouse monocyte-derived chemokine is involved in airway hyperreactivity and lung inflammation. J Immunol (1999) 1.71
Interleukin-18/interleukin-18 binding protein signaling modulates atherosclerotic lesion development and stability. Circ Res (2001) 1.70
Structure-activity relationships in engineered proteins: analysis of use of binding energy by linear free energy relationships. Biochemistry (1987) 1.69
HIV-1 Tat protein mimicry of chemokines. Proc Natl Acad Sci U S A (1998) 1.67
Retracted Prevention of chemotherapy-induced alopecia in rats by CDK inhibitors. Science (2001) 1.67
Outcome of prosthetic knee-associated infection: evaluation of 40 consecutive episodes at a single centre. Clin Microbiol Infect (2006) 1.66
N-terminal methionine-specific peptidase in Salmonella typhimurium. Proc Natl Acad Sci U S A (1987) 1.66
Rat ATP citrate-lyase. Molecular cloning and sequence analysis of a full-length cDNA and mRNA abundance as a function of diet, organ, and age. J Biol Chem (1990) 1.64
Cloning and characterization of a specific receptor for the novel CC chemokine MIP-3alpha from lung dendritic cells. J Exp Med (1997) 1.63
Kinetics of eotaxin generation and its relationship to eosinophil accumulation in allergic airways disease: analysis in a guinea pig model in vivo. J Exp Med (1997) 1.61
Therapeutic effect of neutralizing endogenous IL-18 activity in the collagen-induced model of arthritis. J Clin Invest (2001) 1.59
Management of infection associated with total hip arthroplasty according to a treatment algorithm. Infection (2004) 1.58
Interleukin 10 increases CCR5 expression and HIV infection in human monocytes. J Exp Med (1998) 1.58
Endocytosis and recycling of the HIV coreceptor CCR5. J Cell Biol (2000) 1.56
The platelet collagen receptor glycoprotein VI is a member of the immunoglobulin superfamily closely related to FcalphaR and the natural killer receptors. J Biol Chem (1999) 1.55
Cloning and expression of a cDNA for human thioredoxin. J Biol Chem (1988) 1.55
Co-receptor use by HIV and inhibition of HIV infection by chemokine receptor ligands. Immunol Rev (2000) 1.54
Interaction of chemokines and glycosaminoglycans: a new twist in the regulation of chemokine function with opportunities for therapeutic intervention. Cytokine Growth Factor Rev (2005) 1.53
Selectivity and antagonism of chemokine receptors. J Leukoc Biol (1996) 1.49
Recombinant soluble trimeric CD40 ligand is biologically active. J Biol Chem (1995) 1.49
Conserved residues make similar contacts in two repressor-operator complexes. Science (1990) 1.48
The Swiss-3DImage collection and PDB-Browser on the World-Wide Web. Trends Biochem Sci (1995) 1.44
Structural basis for autorepression of retinoid X receptor by tetramer formation and the AF-2 helix. Genes Dev (2000) 1.44
Role of cysteine62 in DNA recognition by the P50 subunit of NF-kappa B. Nucleic Acids Res (1993) 1.43
Eotaxin: cloning of an eosinophil chemoattractant cytokine and increased mRNA expression in allergen-challenged guinea-pig lungs. Biochem Biophys Res Commun (1994) 1.43
Enhancement of human immunodeficiency virus type 1 infection by the CC-chemokine RANTES is independent of the mechanism of virus-cell fusion. J Virol (1999) 1.42
Differential effects of CC chemokines on CC chemokine receptor 5 (CCR5) phosphorylation and identification of phosphorylation sites on the CCR5 carboxyl terminus. J Biol Chem (1999) 1.42
Chemokine receptors--the next therapeutic target for HIV? Receptors Channels (2001) 1.42
The viral chemokine macrophage inflammatory protein-II is a selective Th2 chemoattractant. Blood (1998) 1.42
Effect of a CC chemokine receptor antagonist on collagen induced arthritis in DBA/1 mice. Immunol Lett (1997) 1.41
Specific sequence elements are required for the expression of functional tumor necrosis factor-alpha-converting enzyme (TACE). J Biol Chem (1999) 1.41
Substrate specificity of human collagenase 3 assessed using a phage-displayed peptide library. J Biol Chem (2000) 1.41
Platelet activation and signal transduction by convulxin, a C-type lectin from Crotalus durissus terrificus (tropical rattlesnake) venom via the p62/GPVI collagen receptor. J Biol Chem (1997) 1.40
Platelet glycoprotein Ia* is the processed form of multimerin--isolation and determination of N-terminal sequences of stored and released forms. Thromb Haemost (1998) 1.39
Role of epithelial interleukin-8 (IL-8) and neutrophil IL-8 receptor A in Escherichia coli-induced transuroepithelial neutrophil migration. Infect Immun (1997) 1.38
Up-regulation of CCR1 and CCR3 and induction of chemotaxis to CC chemokines by IFN-gamma in human neutrophils. J Immunol (1999) 1.37
A broad range of chemokine receptors are used by primary isolates of human immunodeficiency virus type 2 as coreceptors with CD4. J Virol (1998) 1.35
A nucleic acid triple helix formed by a peptide nucleic acid-DNA complex. Science (1995) 1.34
Use of binding energy in catalysis analyzed by mutagenesis of the tyrosyl-tRNA synthetase. Biochemistry (1986) 1.34
Structure of the Tie2 RTK domain: self-inhibition by the nucleotide binding loop, activation loop, and C-terminal tail. Structure (2000) 1.32
Blockade of endogenous IL-18 ameliorates TNBS-induced colitis by decreasing local TNF-alpha production in mice. Gastroenterology (2001) 1.32
The chemokine RANTES is a crucial mediator of the progression from acute to chronic colitis in the rat. J Immunol (2001) 1.32
Broad-range PCR in selected episodes of prosthetic joint infection. Infection (2009) 1.29
Lambda repressor: a model system for understanding protein-DNA interactions and protein stability. Adv Protein Chem (1990) 1.29
Met-RANTES reduces vascular and tubular damage during acute renal transplant rejection: blocking monocyte arrest and recruitment. FASEB J (1999) 1.28
Purification and characterization of human interleukin-1 alpha produced in Escherichia coli. Eur J Biochem (1987) 1.28
The x-ray crystal structure of phosphomannose isomerase from Candida albicans at 1.7 angstrom resolution. Nat Struct Biol (1996) 1.27